Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash and short-term funds | ---- | 0.68%88.36B | ---- | -6.25%92.45B | ---- | -4.33%87.77B | ---- | -5.81%98.61B | ---- | -11.93%91.74B |
| Deposits between Banks and other financial institutions | ---- | 28.88%11.59B | ---- | 1.85%14.68B | ---- | 32.18%8.99B | ---- | 34.42%14.41B | ---- | -33.88%6.8B |
| Lendings to Banks and Other Financial Institutions | ---- | 6.41%48.34B | ---- | 36.12%48.01B | ---- | 53.52%45.43B | ---- | 70.43%35.27B | ---- | 64.00%29.59B |
| Loans and other receivables | ---- | 15.58%1.07T | ---- | 15.35%975.95B | ---- | 12.46%926.71B | ---- | 15.14%846.08B | ---- | 15.41%824.01B |
| Financial assets at fair value | ---- | 5.72%191.92B | ---- | -4.62%168.11B | ---- | 24.73%181.54B | ---- | 43.35%176.26B | ---- | 14.39%145.55B |
| Buying back the sale of financial assets | ---- | -55.21%5.48B | ---- | -51.95%11.9B | ---- | -54.79%12.24B | ---- | 95.71%24.77B | ---- | 49.73%27.07B |
| Derivative financial assets | ---- | -25.93%75.83M | ---- | 53.93%154.24M | ---- | -45.92%102.38M | ---- | -22.73%100.2M | ---- | 25.90%189.3M |
| Interest in associates | ---- | 0.92%5.37B | ---- | 2.13%5.26B | ---- | 6.20%5.32B | ---- | 4.63%5.15B | ---- | 2.16%5.01B |
| Fixed assets | ---- | -1.78%4.35B | ---- | -4.39%4.34B | ---- | -2.17%4.42B | ---- | -1.88%4.54B | ---- | -3.39%4.52B |
| Investment property | ---- | --3.88M | ---- | --4M | ---- | ---- | ---- | ---- | ---- | ---- |
| Goodwill | ---- | -7.59%10.67B | ---- | -7.59%10.67B | ---- | -1.94%11.55B | ---- | -1.94%11.55B | ---- | -19.16%11.78B |
| Deferred tax assets | ---- | 13.01%16.96B | ---- | 8.02%15.38B | ---- | 7.36%15.01B | ---- | 4.27%14.24B | ---- | 2.47%13.98B |
| Other assets | ---- | -1.11%5.04B | ---- | -1.08%4.15B | ---- | 13.69%5.09B | ---- | -15.16%4.2B | ---- | -33.23%4.48B |
| Special items of assets | ---- | 10.21%69.69B | ---- | -1.24%57.96B | ---- | -4.19%63.23B | ---- | 1.51%58.68B | ---- | 8.85%65.99B |
| Total assets | 17.55%2.3T | 16.79%2.25T | 12.65%2.11T | 11.49%2.01T | 11.92%1.95T | 11.27%1.93T | 10.42%1.87T | 14.30%1.81T | 10.82%1.75T | 9.77%1.73T |
| Liabilities | ||||||||||
| Borrowing from the central bank | ---- | 72.40%170.07B | ---- | 1.08%139.58B | ---- | -7.92%98.65B | ---- | 66.55%138.09B | ---- | 45.98%107.13B |
| Interbank and other financial institutions deposits (liabilities) | ---- | -37.03%115.37B | ---- | 7.14%175.72B | ---- | 10.99%183.22B | ---- | 32.69%164.01B | ---- | 36.65%165.08B |
| Customer deposits | ---- | 11.76%1.28T | ---- | 11.95%1.17T | ---- | 11.82%1.15T | ---- | 14.19%1.04T | ---- | 9.54%1.02T |
| Borrowing capital | ---- | 8.48%54.75B | ---- | 5.17%49.52B | ---- | -5.89%50.47B | ---- | 7.35%47.09B | ---- | 17.33%53.63B |
| Tax payable | ---- | 1.84%2.38B | ---- | 3.10%2.04B | ---- | 2.24%2.34B | ---- | -32.10%1.97B | ---- | -6.15%2.29B |
| Bonds issued | ---- | 65.15%324.8B | ---- | 55.76%282.95B | ---- | 6.77%196.67B | ---- | -16.67%181.66B | ---- | 3.81%184.19B |
| Derivative financial liability | ---- | -29.05%80.96M | ---- | 30.21%131.08M | ---- | -41.64%114.1M | ---- | -13.95%100.67M | ---- | 59.43%195.51M |
| Financial assets sold for repurchase | ---- | 50.11%119.09B | ---- | -71.87%18.81B | ---- | 67.93%79.33B | ---- | 22.72%66.85B | ---- | -46.15%47.24B |
| Deferred tax liability | ---- | --8.83M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other accounts and preparations | ---- | 7.70%18.81B | ---- | -5.19%16.43B | ---- | -3.86%17.46B | ---- | -7.60%17.33B | ---- | 0.02%18.17B |
| Total liabilities | 18.47%2.13T | 17.58%2.09T | 13.03%1.94T | 11.61%1.85T | 11.44%1.8T | 10.70%1.77T | 9.73%1.72T | 13.86%1.66T | 10.91%1.61T | 9.67%1.6T |
| Total assets less total liabilities | 7.07%169.83B | 7.70%166.56B | 8.33%164.9B | 10.18%161.67B | 17.71%158.62B | 18.19%154.66B | 18.80%152.23B | 19.46%146.73B | 9.77%134.75B | 10.93%130.86B |
| Equity | ||||||||||
| Share capital | ---- | 0.00%13.89B | ---- | 0.00%13.89B | ---- | 0.00%13.89B | ---- | 0.00%13.89B | ---- | 0.00%13.89B |
| Other equity instruments | ---- | -0.00%20B | ---- | -0.00%20B | ---- | 100.00%20B | ---- | 100.00%20B | ---- | 0.00%10B |
| Capital reserves | ---- | 0.02%15.23B | ---- | 0.02%15.23B | ---- | 0.00%15.23B | ---- | 0.00%15.23B | ---- | 0.00%15.23B |
| Undistributed profit | ---- | 12.37%65B | ---- | 14.80%62.23B | ---- | 16.19%57.85B | ---- | 16.36%54.21B | ---- | 17.80%49.78B |
| Special items of shareholders' equity | ---- | 10.64%21.24B | ---- | 9.60%19.27B | ---- | 9.57%19.19B | ---- | 12.73%17.58B | ---- | 13.41%17.52B |
| Shareholders' equity | ---- | 7.68%162.12B | ---- | 10.12%157.45B | ---- | 18.29%150.56B | ---- | 19.54%142.98B | ---- | 10.74%127.28B |
| Minority interests | ---- | 8.17%4.44B | ---- | 12.64%4.22B | ---- | 14.68%4.1B | ---- | 16.48%3.74B | ---- | 18.16%3.58B |
| Total equity | 7.07%169.83B | 7.70%166.56B | 8.33%164.9B | 10.18%161.67B | 17.71%158.62B | 18.19%154.66B | 18.80%152.23B | 19.46%146.73B | 9.77%134.75B | 10.93%130.86B |
| Total equity and total liabilities | 17.55%2.3T | 16.79%2.25T | 12.65%2.11T | 11.49%2.01T | 11.92%1.95T | 11.27%1.93T | 10.42%1.87T | 14.30%1.81T | 10.82%1.75T | 9.77%1.73T |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.